UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 179

Sortiert nach

The frequency of T regulatory cells modulates the survival of multiple myeloma patients: detailed characterisation of immune status in multiple myeloma

British journal of cancer, 2012-01, Vol.106 (3), p.546-552

2012

Volltextzugriff (PDF)

Allogeneic dendritic cells pulsed with tumor lysates or apoptotic bodies as immunotherapy for patients with early-stage B-cell chronic lymphocytic leukemia

Leukemia, 2005-09, Vol.19 (9), p.1621-1627

2005

Volltextzugriff (PDF)

Vaccination of B-CLL patients with autologous dendritic cells can change the frequency of leukemia antigen-specific CD8+ T cells as well as CD4+CD25+FoxP3+ regulatory T cells toward an antileukemia response

Leukemia, 2008-05, Vol.22 (5), p.1007-1017

2008

Volltextzugriff (PDF)

Epidemic Profile of Shiga-Toxin–Producing Escherichia coli O104:H4 Outbreak in Germany

The New England journal of medicine, 2011-11, Vol.365 (19), p.1771-1780

2011

Volltextzugriff (PDF)

Expression of RHAMM/CD168 and other tumor-associated antigens in patients with B-cell chronic lymphocytic leukemia

International journal of oncology, 2006-07, Vol.29 (1), p.95-103

2006

Volltextzugriff (PDF)

An evaluation of factors predicting long-term response to thalidomide in 234 patients with relapsed or resistant multiple myeloma

British journal of cancer, 2004-11, Vol.91 (11), p.1873-1879

2004

Volltextzugriff (PDF)

Need for Long-term Follow-up in Enterohemorrhagic Escherichia coli—Associated Hemolytic Uremic Syndrome Due to Late-Emerging Sequelae

Clinical infectious diseases, 2012-05, Vol.54 (10), p.1413-1421

2012

Volltextzugriff (PDF)

Eculizumab for Atypical Hemolytic Uremic Syndrome Recurrence in Renal Transplantation

American journal of transplantation, 2012-12, Vol.12 (12), p.3337-3354

2012

Volltextzugriff (PDF)

Complement Factor H–Related Protein 1 Deficiency and Factor H Antibodies in Pediatric Patients with Atypical Hemolytic Uremic Syndrome

Clinical journal of the American Society of Nephrology, 2013-03, Vol.8 (3), p.407-415

2013

Volltextzugriff (PDF)

Large and ongoing outbreak of haemolytic uraemic syndrome, Germany, May 2011

Euro surveillance : bulletin européen sur les maladies transmissibles, 2011-05, Vol.16 (21), p.1

2011

Volltextzugriff (PDF)

Best supportive care and therapeutic plasma exchange with or without eculizumab in Shiga-toxin-producing E. coli O104:H4 induced haemolytic―uraemic syndrome: an analysis of the German STEC-HUS registry

Nephrology, dialysis, transplantation, 2012-10, Vol.27 (10), p.3807-3815

2012

Volltextzugriff (PDF)

Validation of treatment strategies for enterohaemorrhagic Escherichia coli O104:H4 induced haemolytic uraemic syndrome: case-control study

BMJ (Online), 2012-07, Vol.345, p.e4565

2012

Volltextzugriff (PDF)

Surveillance of Shiga toxin-producing Escherichia coli associated bloody diarrhea in Argentina

Revista argentina de microbiología, 2023-10, Vol.55 (4), p.345-354

2023

Volltextzugriff (PDF)

A simple prognostic index for Shigatoxin-related hemolytic uremic syndrome at onset: data from the ItalKid-HUS network

European journal of pediatrics, 2018-11, Vol.177 (11), p.1667-1674

2018

Volltextzugriff (PDF)

Genetics of HUS: the impact of MCP, CFH, and IF mutations on clinical presentation, response to treatment, and outcome

Blood, 2006-08, Vol.108 (4), p.1267-1279

2006

Volltextzugriff (PDF)

Clinical and Laboratory Consequences of Platelet Transfusion in Shiga Toxin–Mediated Hemolytic Uremic Syndrome

Transfusion medicine reviews, 2017-01, Vol.31 (1), p.51-55

2017

Volltextzugriff (PDF)

Urinary neutrophil gelatinase-associated lipocalcin in D+HUS: a novel marker of renal injury

Pediatric nephrology (Berlin, West), 2006-07, Vol.21 (7), p.989-994

2006

Volltextzugriff (PDF)

Effect of an oral Shiga toxin-binding agent on diarrhea-associated hemolytic uremic syndrome in children: a randomized controlled trial

JAMA : the journal of the American Medical Association, 2003-09, Vol.290 (10), p.1337

2003

Volltextzugriff (PDF)

The Complement Factor H R1210C Mutation Is Associated With Atypical Hemolytic Uremic Syndrome

Journal of the American Society of Nephrology, 2008-03, Vol.19 (3), p.639-646

2008

Volltextzugriff (PDF)

Familial haemolytic uraemic syndrome and an MCP mutation

The Lancet (British edition), 2003-11, Vol.362 (9395), p.1542-1547

2003

Volltextzugriff (PDF)

Immunotherapy for patients with acute myeloid leukemia using autologous dendritic cells generated from leukemic blasts

International journal of oncology, 2006-04, Vol.28 (4), p.855-861

2006

Volltextzugriff (PDF)

Costs and health-related quality of life effects of hysterectomy in patients with benign uterine disorders

Acta obstetricia et gynecologica Scandinavica, 2009-12, Vol.88 (12), p.1402-1410

2009

Volltextzugriff (PDF)

Health-related quality of life in patients with common rheumatic diseases referred to a university clinic

Rheumatology international, 2009, Vol.29 (3), p.267-273

2009

Volltextzugriff (PDF)

Complement factor H mutations and gene polymorphisms in haemolytic uraemic syndrome: the C-257T, the A2089G and the G2881T polymorphisms are strongly associated with the disease

Human molecular genetics, 2003-12, Vol.12 (24), p.3385-3395

2003

Volltextzugriff (PDF)

1 – 25 von 179

Suche als RSS-Feed

Aktive Filter

ThemaFemale

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(166)
Mit Volltextzugriff
(157)

Publikationsform

Artikel
(179)

Sprache

Erscheinungsjahr

n.n

Thema

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

The frequency of T regulatory cells modulates the survival of multiple myeloma patients: detailed characterisation of immune status in multiple myeloma

Allogeneic dendritic cells pulsed with tumor lysates or apoptotic bodies as immunotherapy for patients with early-stage B-cell chronic lymphocytic leukemia

Vaccination of B-CLL patients with autologous dendritic cells can change the frequency of leukemia antigen-specific CD8+ T cells as well as CD4+CD25+FoxP3+ regulatory T cells toward an antileukemia response

Epidemic Profile of Shiga-Toxin–Producing Escherichia coli O104:H4 Outbreak in Germany

Prompt plasma exchanges and immunosuppressive treatment improves the outcomes of anti-factor H autoantibody-associated hemolytic uremic syndrome in children

Expression of RHAMM/CD168 and other tumor-associated antigens in patients with B-cell chronic lymphocytic leukemia

An evaluation of factors predicting long-term response to thalidomide in 234 patients with relapsed or resistant multiple myeloma

Need for Long-term Follow-up in Enterohemorrhagic Escherichia coli—Associated Hemolytic Uremic Syndrome Due to Late-Emerging Sequelae

Eculizumab for Atypical Hemolytic Uremic Syndrome Recurrence in Renal Transplantation

Complement Factor H–Related Protein 1 Deficiency and Factor H Antibodies in Pediatric Patients with Atypical Hemolytic Uremic Syndrome

Large and ongoing outbreak of haemolytic uraemic syndrome, Germany, May 2011

Best supportive care and therapeutic plasma exchange with or without eculizumab in Shiga-toxin-producing E. coli O104:H4 induced haemolytic―uraemic syndrome: an analysis of the German STEC-HUS registry

Validation of treatment strategies for enterohaemorrhagic Escherichia coli O104:H4 induced haemolytic uraemic syndrome: case-control study

Surveillance of Shiga toxin-producing Escherichia coli associated bloody diarrhea in Argentina

A simple prognostic index for Shigatoxin-related hemolytic uremic syndrome at onset: data from the ItalKid-HUS network

Genetics of HUS: the impact of MCP, CFH, and IF mutations on clinical presentation, response to treatment, and outcome

Clinical and Laboratory Consequences of Platelet Transfusion in Shiga Toxin–Mediated Hemolytic Uremic Syndrome

Urinary neutrophil gelatinase-associated lipocalcin in D+HUS: a novel marker of renal injury

Effect of an oral Shiga toxin-binding agent on diarrhea-associated hemolytic uremic syndrome in children: a randomized controlled trial

The Complement Factor H R1210C Mutation Is Associated With Atypical Hemolytic Uremic Syndrome

Familial haemolytic uraemic syndrome and an MCP mutation

Immunotherapy for patients with acute myeloid leukemia using autologous dendritic cells generated from leukemic blasts

Costs and health-related quality of life effects of hysterectomy in patients with benign uterine disorders

Health-related quality of life in patients with common rheumatic diseases referred to a university clinic

Complement factor H mutations and gene polymorphisms in haemolytic uraemic syndrome: the C-257T, the A2089G and the G2881T polymorphisms are strongly associated with the disease

Aktive Filter

Suchergebnisse filtern